These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1375974)

  • 1. Antinociceptive effects of intrathecal taurine and calcium in the mouse.
    Hornfeldt CS; Smullin DH; Schamber CD; Sun X; Larson AA
    Life Sci; 1992; 50(24):1925-34. PubMed ID: 1375974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between substance P, calcitonin gene-related peptide, taurine and excitatory amino acids in the spinal cord.
    Smullin DH; Skilling SR; Larson AA
    Pain; 1990 Jul; 42(1):93-101. PubMed ID: 1700356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal antinociceptive effect of substance P on the responses induced by intrathecally injected NMDA in mice.
    Masuyama T; Shimizu T; Iwashita T; Yoshimura N; Fukuda T
    Brain Res; 1996 May; 722(1-2):200-2. PubMed ID: 8813368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A proposed mechanism of action for the antinociceptive effect of intrathecally administered calcium in the mouse.
    Welch SP; Stevens DL; Dewey WL
    J Pharmacol Exp Ther; 1992 Jan; 260(1):117-27. PubMed ID: 1346158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taurine modulates chemical nociception in mice.
    Silva MA; Cunha GM; Viana GS; Rao VS
    Braz J Med Biol Res; 1993 Dec; 26(12):1319-24. PubMed ID: 8136733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphine modulates excitatory amino acid-induced activity in the mouse spinal cord: short-term effects on N-methyl-D-aspartate (NMDA) and long-term effects on kainic acid.
    Yukhananov RYu ; Larson AA
    Brain Res; 1994 May; 646(2):194-200. PubMed ID: 8069663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinociceptive involvement of substance P in the spinal cord of mice: dose effects of substance P on the behavior elicited by intrathecally administered NMDA.
    Masuyama T; Shimizu T
    Brain Res; 1997 Jun; 759(2):241-6. PubMed ID: 9221943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurokinin and NMDA antagonists (but not a kainic acid antagonist) are antinociceptive in the mouse formalin model.
    Murray CW; Cowan A; Larson AA
    Pain; 1991 Feb; 44(2):179-185. PubMed ID: 1711193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral sensitization to kainic acid and quisqualic acid in mice: comparison to NMDA and substance P responses.
    Sun XF; Larson AA
    J Neurosci; 1991 Oct; 11(10):3111-23. PubMed ID: 1719157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CP-96,345, which inhibits [3H] substance P binding, selectively inhibits the behavioral response to intrathecally administered N-methyl-D-aspartate, but not substance P, in the mouse.
    Velázquez RA; Kitto KF; Larson AA
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1231-7. PubMed ID: 9190858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of urethane and ketamine on substance P- and excitatory amino acid-induced behavior in mice.
    Daló NL; Larson AA
    Eur J Pharmacol; 1990 Aug; 184(1):173-7. PubMed ID: 1698643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective inhibition of excitatory amino acids by divalent cations. A novel means for distinguishing N-methyl-D-aspartic acid-, kainate- and quisqualate-mediated actions in the mouse spinal cord.
    Hornfeldt CS; Larson AA
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1064-8. PubMed ID: 2574739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphine (intracerebroventricular) activates spinal systems to inhibit behavior induced by putative pain neurotransmitters.
    DeLander GE; Wahl JJ
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1090-5. PubMed ID: 2481030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chelation of zinc in the extracellular area of the spinal cord, using ethylenediaminetetraacetic acid disodium-calcium salt or dipicolinic acid, inhibits the antinociceptive effect of capsaicin in adult mice.
    Larson AA; Kitto KF
    J Pharmacol Exp Ther; 1999 Feb; 288(2):759-65. PubMed ID: 9918586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathecal N-methyl-D-aspartate (NMDA) activates both nociceptive and antinociceptive systems.
    Raigorodsky G; Urca G
    Brain Res; 1987 Sep; 422(1):158-62. PubMed ID: 2890415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antinociceptive effects of spinally administered nociceptin/orphanin FQ and its N-terminal fragments on capsaicin-induced nociception.
    Katsuyama S; Mizoguchi H; Komatsu T; Sakurada C; Tsuzuki M; Sakurada S; Sakurada T
    Peptides; 2011 Jul; 32(7):1530-5. PubMed ID: 21672568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central antinociceptive effects of non-steroidal anti-inflammatory drugs and paracetamol. Experimental studies in the rat.
    Björkman R
    Acta Anaesthesiol Scand Suppl; 1995; 103():1-44. PubMed ID: 7725891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathecal 5-methoxy-N,N-dimethyltryptamine in mice modulates 5-HT1 and 5-HT3 receptors.
    Alhaider AA; Hamon M; Wilcox GL
    Eur J Pharmacol; 1993 Nov; 249(2):151-60. PubMed ID: 7507056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous dynorphin modulates calcium-mediated antinociception in mice.
    Smith FL; Dewey WL
    Pharmacol Biochem Behav; 1993 Jun; 45(2):383-91. PubMed ID: 8101006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscimol, gamma-aminobutyric acidA receptors and excitatory amino acids in the mouse spinal cord.
    Aanonsen LM; Wilcox GL
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1034-8. PubMed ID: 2467978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.